why do people gain weight back after semaglutide Rebound Stopping Semaglutide, Ozempic and Wegovy Weight Regain After Ozempic: Why

(FDA), , -

Safety & Side Effects of GLP-1 Microdosing GLP-1 microdosing is designed to be gentler than full-dose therapy, but its still a prescription medication and should be used under medical supervision

Excess adipose tissue produces estrogen through aromatization of androgens, disrupting the hypothalamic-pituitary-gonadal axis

Despite the faster escalation, retatrutide achieves greater weight loss (24.2% at 48 weeks versus 22.5% at 72 weeks) due to the additional glucagon receptor activation that increases energy expenditure and fat mobilization

Wegovy is a brand-name medication containing semaglutide, which is a GLP-1 receptor agonist